- Home
- PRCT vs ETV Comparison
PRCT vs ETV Comparison
Compare PRCT & ETV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRCT | ETV |
|---|---|---|
| Founded | 2009 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRCT | ETV |
|---|---|---|
| Price | $32.23 | $14.39 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $51.13 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 252.5K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.75% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $299,907,000.00 | N/A |
| Revenue This Year | $48.34 | N/A |
| Revenue Next Year | $29.35 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 50.07 | N/A |
| 52 Week Low | $27.80 | $11.05 |
| 52 Week High | $89.49 | $13.50 |
Technical Indicators
Market Signals| Indicator | PRCT | ETV |
|---|---|---|
| Relative Strength Index (RSI) | 44.94 | 54.06 |
| Support Level | $33.27 | $14.06 |
| Resistance Level | $36.60 | $14.29 |
| Average True Range (ATR) | 1.98 | 0.15 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 35.17 | 72.94 |
Price Performance
Historical ComparisonAbout PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
About ETV Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.